Analysis Metabolite Name Measured Value Units Exercise Group Sex Type
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+2579Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+2950Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+3276Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+3541Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+3667Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+3767Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+4871Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+5518Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+5917Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+5961Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6517Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6611Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6774Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6981Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+6994Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7455Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7559Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7616Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7799Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+7818Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8257Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8281Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8749Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+8871Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9204Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9286Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+9685Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10090Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10151Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10388Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10669Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10710Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+10738Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11244Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11430Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11589Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11629Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+11847Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+12024Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+12297Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+12393Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+12964Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13178Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13480Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13575Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13677Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+13715Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14318Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14397Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14475Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14476Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14524Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14570Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14692Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14912Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+14913Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15022Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15123Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15192Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15353Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15667Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15763Peak area normalizedYes PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15865Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+15965Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16147Peak area normalizedYes Normal Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16516Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16527Peak area normalizedYes PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16724Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16746Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+16769Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17454Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17743Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17780Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17843Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17865Peak area normalizedNo Normal Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+17906Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18353Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18397Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18677Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18748Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+18874Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+19485Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+19495Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+19776Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+19929Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+19975Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20246Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20305Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20350Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+20870Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21036Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21062Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21170Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21173Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21237Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21355Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21387Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21433Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21450Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21520Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21524Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21662Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+21970Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+22356Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+22682Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+22692Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+22774Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23049Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23055Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23082Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23086Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23309Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23367Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23671Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+23828Peak area normalizedNo LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+24304Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+24403Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+24698Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+24742Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+24889Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25020Peak area normalizedYes LowRisk Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25065Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25203Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25688Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25700Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+25997Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26040Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26230Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26747Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26771Peak area normalizedYes PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+26809Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27147Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27249Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27359Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27446Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+27735Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+28227Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+28487Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29108Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29660Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29820Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29920Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29976Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+29988Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30047Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30157Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30309Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+30713Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+31065Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+31214Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+32578Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+32581Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+32742Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+33070Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+33121Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+33721Peak area normalizedNo Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+33856Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+33939Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+34588Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+35202Peak area normalizedYes Borderline Pressures Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+37271Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+38566Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+38858Peak area normalizedYes PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+38906Peak area normalizedNo Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+39367Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+39461Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40308Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40353Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40354Peak area normalizedNo Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40366Peak area normalizedYes Healthy Male Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+40827Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+41178Peak area normalizedYes Normal Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+41723Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+42159Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+42329Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+42469Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+42484Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+43456Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+43588Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+43684Peak area normalizedNo PAH Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+44590Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+44905Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+45775Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+45777Peak area normalizedNo PAH Male Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+47334Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+48747Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+49316Peak area normalizedYes Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+50660Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+51947Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+52306Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+52918Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+53634Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+61881Peak area normalizedYes Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+64427Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+79279Peak area normalizedNo Borderline Pressures Female Cath
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+80219Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+80417Peak area normalizedYes LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+85575Peak area normalizedNo LowRisk Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+93093Peak area normalizedNo Healthy Female Non-invasive
Reversed phase POSITIVE ION MODELAUROYLCARNITINE (M+H)+99580Peak area normalizedYes Healthy Female Non-invasive

Return to search page
  logo